January 25, 2011

U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use

- Allegra® family of products to be available without a prescription across the U.S. this spring allergy season -

 

U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use
- Allegra® family of products to be available without a prescription across the U.S. this spring allergy season -

Paris, France – January 25, 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its U.S. Consumer Healthcare Division, Chattem, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved the Allegra® (fexofenadine HCl) family of allergy medication products for over-the-counter (OTC) use in adults and children two years of age and older. The Allegra® family of products will be available in the United States without a prescription in March 2011.